Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Decreases By 58.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,500 shares, a decrease of 58.3% from the February 28th total of 3,600 shares. Based on an average trading volume of 66,600 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Trading Down 0.4 %

BCTXW stock opened at $0.10 on Thursday. The company’s 50 day simple moving average is $0.12 and its 200-day simple moving average is $0.24. BriaCell Therapeutics has a 12 month low of $0.07 and a 12 month high of $1.39.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.